Tags
Language
Tags
<<
July 2025
Su Mo Tu We Th Fr Sa
29 30 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31 1 2
    Attention❗ To save your time, in order to download anything on this site, you must be registered 👉 HERE. If you do not have a registration yet, it is better to do it right away. ✌
    https://sophisticatedspectra.com/article/drosia-serenity-a-modern-oasis-in-the-heart-of-larnaca.2521391.html

    DROSIA SERENITY
    A Premium Residential Project in the Heart of Drosia, Larnaca
    ONLY TWO FLATS REMAIN!

    Modern and impressive architectural design with high-quality finishes Spacious 2-bedroom apartments with two verandas and smart layouts Penthouse units with private rooftop gardens of up to 63 m² Private covered parking for each apartment Exceptionally quiet location just 5–8 minutes from the marina, Finikoudes Beach, Metropolis Mall, and city center Quick access to all major routes and the highway Boutique-style building with only 8 apartments High-spec technical features including A/C provisions, solar water heater, and photovoltaic system setup.
    Drosia Serenity is not only an architectural gem but also a highly attractive investment opportunity. Located in the desirable residential area of Drosia, Larnaca, this modern development offers 5–7% annual rental yield, making it an ideal choice for investors seeking stable and lucrative returns in Cyprus' dynamic real estate market. Feel free to check the location on Google Maps.
    Whether for living or investment, this is a rare opportunity in a strategic and desirable location.

    1. Home
    2. Magazines
    3. Bio Spectrum - June 2019

    Bio Spectrum - June 2019

    Posted By: Pulitzer
    Date: 27 Jul 2019 11:35:19
    Bio Spectrum - June 2019

    Bio Spectrum - June 2019
    English | 54 pages | True PDF | 17.0 MB


    INDIAN BIOPHARMA INDUSTRY GROWING AT 12% CROSSES ₹ 22,000 CRORE

    BioSpectrum Top 20 Biopharma Special

    The Indian Biopharma Industry with over 300 companies is growing at 12 per cent growth against the pharma industry growth which is passing through tough situation postGST, ban on manufacture, sale and distribution of over 340 fixed dose combination (FDC) drugs. For the year 2018-19 the Biopharma Industry crossed Rs 22,124 crore over previous year’s revenue of Rs 18,290 core with exports comprising of Rs 14,423 crore in 2018-19 witnessing growth over last year’s exports of 13,925 crore.

    More issues archive

    Bio Spectrum - June 2025 01.06.2025
    Bio Spectrum - May 2025 01.05.2025
    Bio Spectrum - April 2025 01.04.2025
    Bio Spectrum - March 2025 01.03.2025
    UPWARDS